Annexin Pharmaceuticals: Strategy Update - Redeye

Annexin Pharmaceuticals' CEO, Anders Haegerstrand, Chief Scientific and Medical Officer, Anna Frostegård, and Head of Therapeutic Area Oncology, Alain Thibault, present the company’s strategic priorities and its commercial roll-out. Watch the replay from March 7.

Länk till analysen i sin helhet: https://www.redeye.se/video/event-presentation/888241/annexin-strategy-update-march-7-2023?utm_source=finwire&utm_medium=RSS